Busulfan disposition and hepatic veno-occlusive disease in children undergoing bone marrow transplantation
- 1 January 1995
- journal article
- research article
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 37 (3) , 247-253
- https://doi.org/10.1007/bf00688324
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Busulfan disposition below the age of three: alteration in children with lysosomal storage disease.1993
- Veno-occlusive Disease of the Liver and Multiorgan Failure after Bone Marrow Transplantation: A Cohort Study of 355 PatientsAnnals of Internal Medicine, 1993
- Allogeneic bone marrow transplantation in high-risk myeloid disorders using busulfan, cytosine arabinoside and cyclophosphamide (BAC).1992
- Pharmacokinetics of high-dose busulphan in relation to age and chronopharmacologyCancer Chemotherapy and Pharmacology, 1991
- Busulfan and Veno-occlusive Disease of the LiverAnnals of Internal Medicine, 1990
- High-dose melphalan dosage adjustment: possibility of using a test-doseCancer Chemotherapy and Pharmacology, 1989
- Pharmacokinetics of busulfan: correlation with veno-occlusive disease in patients undergoing bone marrow transplantationCancer Chemotherapy and Pharmacology, 1989
- Gas chromatographic—mass spectrometric assay for busulfan in biological fluids using a deuterated internal standardJournal of Chromatography B: Biomedical Sciences and Applications, 1988
- Pharmacokinetics of high-dose melphalan in children and adultsCancer Chemotherapy and Pharmacology, 1986
- Venocclusive Disease of the Liver after Bone Marrow Transplantation: Diagnosis, Incidence, and Predisposing FactorsHepatology, 1984